Keyphrases
Agonistic
11%
Apoptosis
22%
Cancer Gene Therapy
11%
Cancer Therapy
11%
Chimeric Antigen Receptor T Cells (CAR-T)
100%
Cytolysis
11%
Cytotoxicity
22%
Human Peripheral Blood Lymphocytes
11%
Induced Apoptosis
100%
Jurkat Cells
22%
Jurkat T Cells
11%
KHYG-1
22%
Ligand-receptor Binding
100%
Monoclonal Antibody
11%
Multiple Tumors
11%
NK Cell Lines
11%
Peripheral Blood Lymphocytes
11%
Receptor 1
100%
ScFv
55%
Single-chain Antibody Fragment
11%
T Cell Lines
11%
TRAIL Receptors
77%
Tumor Cells
100%
Tumor Necrosis Factor-related Apoptosis-inducing Ligand (TRAIL)
100%
Medicine and Dentistry
Cancer Gene Therapy
12%
Cancer Therapy
12%
Cell Line
25%
Chimeric Antigen Receptor
100%
Cytolysis
12%
Cytotoxicity
25%
Death Receptor 4
87%
Jurkat Cells
25%
Lymphocyte
25%
Monoclonal Antibody
12%
Natural Killer Cell
12%
Programmed Cell Death
100%
Proteus Syndrome
12%
Receptor
12%
Single Chain Fragment Variable Antibody
25%
T Cell
12%
Target Cell
37%
Tumor Cell
100%
Tumor Necrosis Factor Related Apoptosis Inducing Ligand
25%
Tumor Necrosis Factor Related Apoptosis Inducing Ligand Receptor
100%
Agricultural and Biological Sciences
Cell Line
20%
Chimeric Antigen Receptor
100%
Cytolysis
10%
Cytotoxicity
20%
Gene Therapy
10%
Jurkat Cells
20%
Monoclonal Antibody
10%
Natural Killer Cell
10%
Peripheral Blood Lymphocyte
20%
Programmed Cell Death
100%
Receptor
100%
Single-Chain Variable Fragment
20%
T Cell
10%
Target Cell
30%
Tnf Related Apoptosis Inducing Ligand
69%
Tumor Necrosis Factor
100%
Immunology and Microbiology
Cell Line
20%
Chimeric Antigen Receptor
100%
Cytolysis
10%
Cytotoxicity
20%
Monoclonal Antibody
10%
Natural Killer Cell
10%
Peripheral Blood Lymphocyte
20%
Single-Chain Variable Fragment
20%
T Cell
10%
Target Cell
30%
TNF related apoptosis inducing ligand
100%
Tumor Cell
100%
Tumor Necrosis Factor Related Apoptosis Inducing Ligand
100%